Nuvation Bio Inc. Major Shareholders & Ownership History
Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
---|---|---|---|---|---|
FMR LLC | 02/13/2025 | 45.29 M | $120.46 M | 54.88% | 16.55% |
DECHENG CAPITAL LLC | 02/14/2025 | 25.95 M | $69.04 M | 0.00% | 9.49% |
BLACKROCK, INC. | 02/07/2025 | 18.54 M | $49.32 M | 9.24% | 6.78% |
VANGUARD GROUP INC | 02/11/2025 | 15.73 M | $41.85 M | 45.42% | 5.75% |
OMEGA FUND MANAGEMENT, LLC | 02/14/2025 | 13.07 M | $34.77 M | 0.00% | 4.78% |
OCTAGON CAPITAL ADVISORS LP | 02/14/2025 | 9.20 M | $24.48 M | -24.39% | 3.36% |
LAURION CAPITAL MANAGEMENT LP | 02/14/2025 | 6.49 M | $17.27 M | 307.89% | 2.37% |
GEODE CAPITAL MANAGEMENT, LLC | 02/12/2025 | 4.95 M | $13.17 M | 22.90% | 1.81% |
STATE STREET CORP | 02/14/2025 | 4.60 M | $12.24 M | 10.41% | 1.68% |
BIOIMPACT CAPITAL LLC | 02/14/2025 | 4.16 M | $11.08 M | 100.00% | 1.52% |
TANG CAPITAL MANAGEMENT LLC | 02/14/2025 | 3.90 M | $10.37 M | 0.00% | 1.43% |
ABRAMS CAPITAL MANAGEMENT, L.P. | 02/07/2025 | 3.81 M | $10.14 M | 0.00% | 1.39% |
REDMILE GROUP, LLC | 02/14/2025 | 3.03 M | $8.06 M | 0.00% | 1.11% |
AISLING CAPITAL MANAGEMENT LP | 02/12/2025 | 2.54 M | $6.76 M | 0.00% | 0.93% |
MILLENNIUM MANAGEMENT LLC | 02/14/2025 | 2.48 M | $6.59 M | 82.72% | 0.91% |
CITADEL ADVISORS LLC | 02/14/2025 | 2.18 M | $5.79 M | -21.04% | 0.80% |
NORTHERN TRUST CORP | 02/14/2025 | 2.09 M | $5.55 M | 37.00% | 0.76% |
GOLDMAN SACHS GROUP INC | 02/11/2025 | 2.03 M | $5.40 M | 53.29% | 0.74% |
CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 02/06/2025 | 1.95 M | $5.18 M | 39.60% | 0.71% |
UBS GROUP AG | 02/14/2025 | 1.85 M | $4.92 M | 297.91% | 0.68% |
NUVEEN ASSET MANAGEMENT, LLC | 02/14/2025 | 1.53 M | $4.08 M | -2.93% | 0.56% |
BARCLAYS PLC | 02/13/2025 | 1.28 M | $3.40 M | 5.04% | 0.47% |
EDBI PTE LTD | 02/04/2025 | 1.27 M | $3.38 M | 0.00% | 0.46% |
DIMENSIONAL FUND ADVISORS LP | 02/13/2025 | 1.23 M | $3.26 M | -26.07% | 0.45% |
TWO SIGMA INVESTMENTS, LP | 02/14/2025 | 1.15 M | $3.06 M | 0.52% | 0.42% |
MORGAN STANLEY | 02/14/2025 | 1.07 M | $2.85 M | -9.30% | 0.39% |
WEXFORD CAPITAL LP | 02/14/2025 | 946.22 K | $2.52 M | 45.18% | 0.35% |
ALGERT GLOBAL LLC | 02/14/2025 | 871.47 K | $2.32 M | 202.40% | 0.32% |
CITIGROUP INC | 02/12/2025 | 852.76 K | $2.27 M | 2.55% | 0.31% |
AQR CAPITAL MANAGEMENT LLC | 02/14/2025 | 821.36 K | $2.18 M | 10.63% | 0.30% |
PALO ALTO INVESTORS LP | 02/14/2025 | 772.65 K | $2.06 M | 0.00% | 0.28% |
WELLINGTON MANAGEMENT GROUP LLP | 02/12/2025 | 676.02 K | $1.80 M | 8.34% | 0.25% |
SIO CAPITAL MANAGEMENT, LLC | 02/14/2025 | 668.12 K | $1.78 M | 0.00% | 0.24% |
RENAISSANCE TECHNOLOGIES LLC | 02/13/2025 | 566.80 K | $1.51 M | -44.92% | 0.21% |
BANK OF NEW YORK MELLON CORP | 02/04/2025 | 518.58 K | $1.38 M | 2.82% | 0.19% |
TWO SIGMA ADVISERS, LP | 02/14/2025 | 476.40 K | $1.27 M | -10.77% | 0.17% |
SWISS NATIONAL BANK | 02/10/2025 | 426.70 K | $1.14 M | 47.09% | 0.16% |
CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. | 02/10/2025 | 422.26 K | $1.12 M | 6.43% | 0.15% |
AMERICAN CENTURY COMPANIES INC | 02/11/2025 | 411.17 K | $1.09 M | 20.39% | 0.15% |
01/29/2025 | 391.75 K | $1.04 M | 100.00% | 0.14% | |
UBS ASSET MANAGEMENT AMERICAS INC | 02/14/2025 | 347.81 K | $925.16 K | 54.16% | 0.13% |
PANAGORA ASSET MANAGEMENT INC | 02/13/2025 | 341.76 K | $909.09 K | -43.55% | 0.12% |
INVESCO LTD. | 02/13/2025 | 330.39 K | $878.83 K | 2.27% | 0.12% |
INTELLECTUS PARTNERS, LLC | 02/07/2025 | 280.91 K | $747.21 K | 7.46% | 0.10% |
ALPS ADVISORS INC | 02/13/2025 | 272.15 K | $723.92 K | 100.00% | 0.10% |
RHUMBLINE ADVISERS | 01/30/2025 | 263.81 K | $701.71 K | -0.97% | 0.10% |
GSA CAPITAL PARTNERS LLP | 02/07/2025 | 242.25 K | $644.00 K | 223.30% | 0.09% |
POINT72 ASSET MANAGEMENT, L.P. | 02/14/2025 | 226.82 K | $603.35 K | -18.03% | 0.08% |
PRICE T ROWE ASSOCIATES INC /MD/ | 02/14/2025 | 225.03 K | $599.00 K | 4.53% | 0.08% |
LEGAL & GENERAL GROUP PLC | 02/13/2025 | 224.83 K | $597.94 K | 53.32% | 0.08% |
Nuvation Bio Inc. institutional Ownership - FAQ's
During the previous two years, 157 institutional investors and hedge funds held shares of Nuvation Bio Inc.. The most heavily invested institutionals were:
Marquette Asset Management, LLC: 0
WEALTH ENHANCEMENT ADVISORY SERVICES, LLC: 0
Abacus Planning Group, Inc.: 0
Cerity Partners LLC: 0
FMR LLC: 45.29 M
Decheng Capital LLC: 25.95 M
72.27% of Nuvation Bio Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 194.56 M shares in the last 24 months. This purchase volume represents approximately $478.61 M in transactions.